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Abstract
BACKGROUND: Understanding the mechanisms of the behavioral disorders’ emergence under the influence of chronic 
stress is the most important aspect of the subsequent development of a strategy for its therapy and prevention. Changes 
in the oxidative metabolism processes can be decisive in the development of the pathogenetic cascade in the brain. 
Information about these processes can be obtained by studying protein carbonylation, lipid peroxidation, and catalase 
activity (CA). The complexity of the therapeutic impact in various behavioral disorders implies the search for new 
pharmacological substances and the study of the previously known drugs’ effects based on the available scientific data.
AIM: The aim of the study was to study the reactive carbonyl derivatives of proteins (RCDP), malondialdehyde 
(MDA), and CA in the brain of rats after therapy following chronic unpredictable moderate stress (CUMS).
METHODS: Forty male outbred rats weighing 450–500 g were used in this study. For 21 days, all animals were 
exposed to the diverse stress factors for developing the CUMS. The animals were divided into four groups of 10 
rats, each using randomized selection. The rats of one group were euthanized by decapitation with subsequent brain 
harvesting (Group 4). Remaining three groups of rats were treated with placebo (Group 1), harmine hydrochloride 
(Group 2), and amitriptyline (Group 3) for 21 days. Upon completion of therapy, all rats were also euthanized by 
decapitation with subsequent brain harvesting. The levels of RCDP, MDA, and CA were studied in their brain, and 
after that, we compared the multiple studied indicators in four groups.
RESULTS: The results of the rat brain examinations in four groups showed that RCDP level in Group 2 was significantly 
lower than in Group 4 (p = 0.000). Similarly, in Group 1, it was lower than in Group 4 (p = 0.021), plus, it did not differ 
statistically from the harmine hydrochloride group (p = 1,000). Indicators of Groups 3 and 4 did not have any significant 
differences in RCDP level, too, (p = 0.799); however, the RCDP level in Group 2 was significantly lower than in Group 
3 (p = 0.040). MDA indicators did not show significant differences; however, a tendency for lower values was revealed 
in Group 1 (p = 0.233) and Group 2 (p = 0.151). CA in Group 4 was lower than that in Group 1 (p = 0.000), Group 2 
(p = 0.001), and Group 3 (p = 0.003) contemporaneously, while all treatment groups were comparable (p = 1.000).
CONCLUSION: The result of exposure to chronic stress can be reproduced with the best quality in the CUMS 
model. The neurobiological foundations of the model make it possible to assess biochemical markers of oxidative 
metabolism and evaluate the possibilities of pharmacological correction of stress-induced behavioral disorders. To 
assess the mechanisms of autoregulation of oxidative metabolism, this study included a placebo group (Group 1), 
the level of RCDP in which was significantly higher in comparison with Group 3 and Group 4 and slightly lower than 
in Group 2. In this study, harmine hydrochloride demonstrated activity exceeding amitriptyline, particularly limiting 
the process of protein carbonylation, not noted for amitriptyline. According to the results of the RCDP assessment 
in the CUMS model, the process of protein carbonylation can be considered to be one of the significant factors in 
the deactivation of neurotransmitters. The CA levels determined in all groups allowed us to consider this marker as 
the most sensitive to the effects of stress, which possibly has an inhibitory effect on catalase, as its activity in all 
groups after therapy was more than two-fold higher than in animals right after CUMS. We can assume that CA plays 
an important role in starting the processes of autoregulation of oxidative metabolism. The study was carried out as 
a part of the implementation of the scientific and technical program No. BR05236584 “Development of new herbal 
preparations and their pharmacological and clinical studies” (O.0820). (2018–2020) in the priority area, “Life and 
Health Sciences.”
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Introduction
The impact of chronic stress on the human 
population around the world is of the greatest 
interest to researchers. Chronic stress contributes to 
the formation of a significant number of behavioral 
reactions similar to endogenous psychopathological 
syndromes, and the mechanisms for the development 
of such conditions are continuously studied [1]. The 
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most common response to chronic stress exposure 
is depressive disorder [2]. However, the clinical 
classification of diseases includes a wide variety 
of stress-related depressive, anxious, dissociative, 
somatoform, and mixed reactions associated with 
impaired adaptation [3]. The type of stress response 
is assumed to develop depending on individual’s 
biological and personal characteristics.
Research continues on the effects of stress on 
various biochemical patterns of behavioral disorders. 
The generation of reactive oxygen species in tissues 
and organs, probably, due to neurohumoral regulation, 
plays a significant role in the damaging effect of chronic 
stress [4]. The accumulation of reactive oxygen species 
in the brain leads to a disturbance in the balance of 
the oxidative metabolism and the local homeostasis 
maintenance processes due to weak antioxidant 
protection inherent in brain tissues [5]. This results in 
the macromolecular oxidation of proteins, lipids, and 
DNA, leading to the formation and accumulation of large 
molecules capable of inactivating proteasomes [6]. This 
mechanism is considered to be a pathogenetic variant 
of the neurodegenerative disease development and 
could be the cause of explaining the prolonged course 
of behavioral disorders after the exposure to stress 
factors ends.
Protein modification under the influence of the 
increased concentration of reactive oxygen species 
can happen through carbonylation. The formation 
of carbonyl derivatives of proteins occurs during the 
oxidation of amino acid residues as a result of interaction 
with carbonyl-containing oxidized lipids and through 
other ways leading to the formation of protein carbonyl. 
In the long run, after the carbonylation, proteins lose 
their catalytic functions, thus, significantly reducing their 
biological activity. Due to high receptor concentration in 
the brain tissues, oxidative modification of the proteins 
also leads to a decreased metabolic activity of neurons.
Another indicator that is of interest to 
researchers is malondialdehyde (MDA), the function 
of which is still being studied. It is known that MDA, 
being a degradation product of arachidonic acid and 
polyunsaturated fats, can act as a signaling molecule, 
participate in the regulation of gene expression, and 
cause DNA damage when excessively accumulating in 
tissues [7].
The study of the processes of antioxidant 
protection in tissues is most accessible with the 
evaluation of the catalase activity (CA), an enzyme 
that destroys toxic hydrogen peroxide. However, 
the accumulation of hydrogen peroxide under some 
conditions can also have a protective effect during 
revascularization [8]. We have not found any data on its 
effect on the revascularization process in the brain. CA 
is a marker studied in various pathological conditions, 
including diseases of the central nervous system. 
Catalase exhibits the properties of a nonspecific 
amyloid-binding protein; this fact undoubtedly 
increases its role in the development and progression of 
degenerative brain lesions. The neuroprotective effect 
of catalase is achieved due to its overexpression and 
ability to directly bind proteins of the amyloid spectrum 
and prion proteins [9]. We evaluated CA to assess 
the antioxidant protection in the chronic unpredictable 
moderate stress (CUMS) model during therapy and 
to detect the probable inhibitory effect of the studied 
drugs early.
The therapy of neurotic disorders, including 
stress-induced disorders, is a problem of current 
interest in psychiatry. The development of the leading 
complex of symptoms depends on both neurobiological 
and neuropsychological factors. Reproducing the 
stress-generating disorder in an animal experiment is 
possible only when comparing neurobiological patterns, 
including biochemical ones. In the literature, there 
are no data on the dynamics of oxidative metabolism 
changes when using drugs with an antidepressant 
effect, due to the dominant importance of behavioral 
reactions during this type of therapy. However, a 
wide range of behavioral disorders and individual 
sensitivity to pharmacological drugs determine the 
ongoing search for the new agents of combined action 
with antidepressant and anxiolytic effects. Most of 
the research is a process of investigating drugs with 
antidepressant effects in the CUMS model, which is 
currently considered valid [10].
Harmine hydrochloride is a water-soluble form 
of the indole alkaloid harmine isolated from an ethanol 
extract of the Peganum harmala L. roots. Harmine, 
showing properties of a MAO-B inhibitor and, in high 
concentrations, also is MAO-A inhibitor, is able to suppress 
the inactivation of monoamine mediators [11]. Harmine 
was previously used in the treatment of Parkinsonism 
but was supplanted with the advent of new antiparkinson 
drugs [12]. This study of harmine was continued from 
the standpoint of its antihypoxant, antidepressant, anti-
anxiety, antiparkinsonian, and anticarcinogenic and other 
types of activity [13], [14], [15], [16].
According to the literature data, there is little 
information about markers of the oxidative metabolism 
state such as reactive carbonyl derivatives of protein 
(RCDP), MDA, and CA, in brain under conditions 
of chronic unpredictable stress and during the 
subsequent therapy. There are no data from studies on 
the effect of harmine hydrochloride on the processes 
of oxidative metabolism in the brain. Possible further 
studies of the harmine hydrochloride effect on the 
oxidative metabolism in brain and high bioavailability 
of its water-soluble form allow to contemplate it as a 
promising drug for the correction of stress-induced 
disorders.
The aim of our study was to examine changes 
in the levels of RCDP, MDA, and CA in brain of rats after 
therapy with harmine hydrochloride and amitriptyline 
following CUMS.
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Methods
The study of the effects of the psychoactive 
substance requires the use of an experimental model 
that reproduces the symptoms of the studied conditions 
in animals [10]. In our research, a modified “Chronic 
unpredictable moderate stress” (CUMS) model was 
used [17], [18]. CUMS is considered to be a reference 
model and is recommended for use to provoke the 
emergence of stress-induced behavioral disorders 
in experimental animals. Based on the reference 
model, we developed a personalized algorithm, the 
effectiveness of which in inducing stress associated 
disorders was assessed in standardized behavioral 
tests [19], [20].
Selection and description of participants
Forty male outbred rats weighing 450–500 g 
were used in this study. The animals were kept under 
standard laboratory conditions (25 ± 2°C, humidity 
60–70%), five rats per cage, maintaining a 12-h natural 
day-night cycle with free access to standard food and 
water. The quarantine and keeping conditions of the 
animals before the start of the experiment met the 
established requirements.
Technical information
Experimental animals were exposed to chronic 
unpredictable stress for 21 days to form a stress-induced 
behavioral disorder. After that, the animals were divided 
by randomization into 4 groups, 10 rats each. Animals 
of the 4th group were euthanized by decapitation with 
subsequent harvesting of the brain. The experiment was 
continued using 30 animals, divided into three groups, 
which were subjected to a therapeutic effect for 21 days 
using placebo in the Group 1, harmine hydrochloride in 
the Group 2, and amitriptyline in the Group 3. On the 
43rd day of the experiment, the animals were euthanized 
by decapitation, followed by a brain harvesting. After 
removal from the cranium, the brain of the animals was 
subjected to grinding, freezing, and homogenization 
procedures for further spectrophotometric analysis.
The study was conducted in accordance with 
the requirements of the European Convention for the 
Protection of Vertebrate Animals Used in Experiments 
and Other Scientific Purposes (Strasbourg, 1986), 
requirements of GLP OECD, EAEU Rules of Good 
Laboratory Practice No. 81, order of the Ministry of 
Health and Social Development of the Republic of 
Kazakhstan No. 392 dated May 25, 2015. The study 
was approved by the decision of the Committee on 
Bioethics of the Karaganda Medical University on June 
17, 2019, protocol No. 65.
Experimental procedure for CUMS model
The stress model was formed in animals 
during a 21-day period (3 cycles of 7 days each), when 
all animals were exposed to CUMS according to the 
scheme presented in Table 1, listing the recommended 
time for the formation of a behavioral disorder in 
experimental animals. [18].
Table 1: CUMS model
Day Type of exposure Starting 
time
Duration
1 Narrow cell (limiting the space of the cell by half due 
to the installation of an additional partition in the cell)
12.00 20 h
2 Food deprivation 8.00 24 h
3 Immobilization in a case (animals were placed in 
individual cases, which do not deprive them of 
the ability to move, but greatly limit the space for 
movement)
10.00 4 h
4 Artificial shading during daylight hours 6.00 15 h
5 Water deprivation 8.00 10 h
5 Artificial light during night hours 19.00 15 h
6 Full immobilization (animals were placed in individual 
canisters, depriving them of the ability to move)
10.00 2 h
7 Behavioral tests 10.00 8 h with 1 h break 
between tests
CUMS: Chronic unpredictable moderate stress.
Upon the formation of the stress-induced 
disorder model, from the 22nd day, the daily exposure 
to stress factors was terminated and the experiment 
continued under standard conditions for the rats.
Behavioral assessments
Conducting the trial using behavioral tests 
was part of the stress-induced disorder development 
model as one of the stress factors. Assessment in 
behavioral tests was carried out before the start of 
the experiment and at days 7, 14, 21, 28, 35, and 42. 
Signs of stress-induced disorder were revealed in 
animals of all groups, and their severity was evaluated 
using standard protocols in the “open field test” [21], 
“the elevated cross-maze test” [22], “tail-hanging 
test” [23], and “sucrose preference test” [24], however, 
reporting of the results of the tests is not the purpose 
of this article. According to the approved procedure, 
additional stressors were not used on the day of the 
behavioral testing. A rest period of 1 h was allowed 
between tests.
Drug treatment
After the formation of the model stress-
induced disorder from the 22nd day forward, every 
day at 10.00, the rats received therapy by intragastric 
tube administration. Animals of the Group 1 received 
2 ml of placebo (NaCl 0.9%), Group 2–4.5 mg/
kg individually of harmine hydrochloride, and the 
Group 3–4.5 mg/kg individually of amitriptyline. 
The treatment lasted 21 days, as the sources note 
such duration as the shortest time recommended 
for the psychotherapeutic effect of the drug to be 
achieved [25].
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Spectrophotometric study
Twenty-four hours after the last dose, all animals 
were euthanized by decapitation, the skull was opened 
and the brain harvested. The brain was washed with 0.9% 
NaCl solution, crushed into small pieces, and flooded 
with liquid nitrogen to preserve its native characteristics 
until biochemical analysis; after that, the brain was stored 
in a freezer at −18°C. Then, the brain was homogenized 
in a Teflon homogenizer in 0.1 M phosphate buffer (pH 
7.4) and centrifuged while being cold to obtain 10% w/v 
brain tissue homogenate to determine the parameters 
of RCDP, MDA, and CA. The resulting samples were 
pretreated according to the recommended procedures 
and subjected to spectrophotometric analysis using 
a PD-303UV digital UV-VIS spectrophotometer, 
manufactured by APEL, Japan.
Determining RCDPs
We measured the concentration of RCDP 
following the well-tested protocol of Arutyunyan et al. 
(2000) [26]. The assessment method is based on the 
interaction of oxidized amino acid residues of proteins 
with 2,4-dinitrophenylhydrazine (2,4-DNPH) with the 
formation of 2,4-dinitrophenylhydrazones, which are 
recorded spectrophotometrically. A 1% solution of 
streptomycin sulfate was used to precipitate nucleic 
acids, which are known to be capable of increasing the 
level of carbonyl compounds. We added 9 volumes of 
brain homogenate to 1 volume of streptomycin sulfate 
solution, left the solution for 15 min, then centrifuged it 
for 10 min and used the supernatant for analysis.
The resulting material was divided into 2 equal 
parts. We added 0.5 mL of a 10 mM solution of 2,4-
DNPH in 2 M HCl solution to the experimental sample 
and the same amount of 2 M HCl solution to the control 
sample. The samples were left at room temperature 
for 1 h, being shaken occasionally every 10–15 min. 
Then, we added 0.5 mL of a 20% trichloroacetic acid 
(TCA) solution to both samples and centrifuged them 
at 11,000 g, decanted the supernatant, and washed the 
precipitate 3 times with 1 mL of a mixture of ethanol and 
ethyl acetate (1:1) to eliminate unreacted 2,4-DNPG 
and lipid additives. Then, the precipitate was dissolved 
in 0.6 ml of guanidine solution. To eliminate insoluble 
components, the liquid was centrifuged for 3 min. The 
amount of the formed 2,4-DNP-hydrazones was recorded 
at the maximum adsorption (wavelength 370 nm) in 
comparison with the control sample. Concentration of 
carbonyl derivatives was calculated using the molar 
absorption coefficient of 22,000 mol−1cm−1, RCDP 
values were given in nmol/mL.
Determining MDA
Lipid peroxidation was determined by 
quantifying the thiobarbituric acid-reactive substances 
(Ohkawa et al., 1979). One aliquot (75 μL) of 
homogenized tissue (0.1 ± 0.005 g/1 mL of water) was 
diluted with Tris-HCl buffer, pH 7.4 (175 μL; 0.15 M). 
After 30 min of incubation at 37°C, we added 500 μL 
of thiobarbituric acid (0.3% [w/v]) dissolved in TCA 
(15% [w/v]). Then, the samples were boiled for 1 h and 
centrifuged at 6000 rpm for 15 min. The level of lipid 
peroxidation was expressed as μmol/mg of protein of 
MDA at 540 nm [27].
Determining CA
The method of Aebi (1984) was used to 
determine the activity of catalase in brain tissues 
homogenate. First, we incubated the homogenate in 
the reaction mixture containing 0.1 mL homogenate 
and 0.85 mL potassium phosphate buffer (50 mM 
and pH 7.0) at room temperature for 10  min. Then, 
we launched the reaction by adding 0.05 mL H2O2 
(30 mM prepared in potassium phosphate buffer, 
50 mM, and pH 7.0). A decrease in the absorbance 
was recorded by a spectrophotometer at an excitation 
of 240 nm for 3 min. The specific activity of catalase 
was calculated as 1  μmol H2O2 decomposed U/mg 
protein [28].
Statistics
The results were statistically processed using 
SPSS.Statistics.v22.Multilingual-EQUiNOX (SPSS 
Inc.) software. Analysis of the obtained data was 
conducted using descriptive statistics. To assess the 
studied indicators of oxidative metabolism, multiple 
comparisons were made across groups using the 
nonparametric Kruskal–Wallis test (α = 0.05).
Results
The analysis of descriptive statistics presented 
in Table 2 made it possible to estimate the values of the 
studied indicators and the absolute difference between 
groups based on Me (Q25; Q75). Hence, according to 
the available data on the Group 4 indicators, after the 
CUMS model formation, the level of RCDP Me = 0.074 
(0.070; 0.078), which exceeds the indicators in all groups 
receiving therapy, including placebo, by 1.5–2 times. 
At the same time, the CA in the treatment groups is 
Table 2: Descriptive statistics by group
Indicator Me (Q25; Q75) Me (Q25; Q75) Me (Q25; Q75) Me (Q25; Q75)
Group 1 Group 2 Group 3 Group 4
RCDP 0.042  
(0.041; 0.053)
0.037  
(0.033; 0.048)
0.058  
(0.052; 0.060)
0.074 
(0.070; 0.078)
MDA 0.047 
(0.043; 0.050)
0.045  
(0.033; 0.048)
0.051  
(0.049; 0.053)
0.055  
(0.050; 0.066)
CA 0.503 
(0.492; 0.559)
0.492  
(0.462; 0.522)
0.481  
(0.476; 0.053)
0.232 
(0.222; 0.243)
RCDP: Reactive carbonyl derivatives of proteins.
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2 or more times higher than this indicator in Group 4 
Me = 0.232 (0.222; 0.243). However, the MDA level 
Me = 0.055 (0.050; 0.066) does not differ significantly 
between the groups.
We verified these tendencies by multiple 
comparisons between groups using the nonparametric 
Kruskal–Wallis test (α = 0.05). Statistically significant 
differences were accepted at p ≤ 0.05.
When comparing the RCDP indicators in the 
rats’ brains between four groups, according to the 
data presented in Table 3, we found that the group 
receiving harmine hydrochloride therapy (Group 2) had 
a significantly lower level of RCDP than Group 4 right 
after stress (p = 0.000). Placebo therapy in Group 1 
also showed a significantly lower level of RCDP than 
in Group 4 (p = 0.021) and did not differ from Group 
2 of harmine hydrochloride (p = 1,000). Indicators of 
Groups 3 and 4 did not show significant differences in 
the RCDP level (p = 0.799). Plus, the RCDP level in the 
harmine hydrochloride group (Group 2) was significantly 
lower than in the amitriptyline group (p = 0.040); 
however, there were no significant differences between 
the amitriptyline (Group 3) and placebo (Group 1) 
(p = 0.925).
Table 3: RCDP levels in brain in the groups
Kruskal–Wallis H test (α = 0.05) H (3, n = 40) =19.88 p = 0.000
RCDP Group 1 Group 2 Group 3 Group 4
Group 1 1.000 0.925 0.021
Group 2 1.000 0.040 0.000
Group 3 0.925 0.040 0.799
Group 4 0.021 0.000 0.799
RCDP: Reactive carbonyl derivatives of protein
The results of the MDA level comparison 
between the groups, presented in Table 4, did not 
demonstrate any statistically significant differences. 
However, a tendency toward a decrease of MDA level 
was noted in placebo Group 1 (p = 0.233) and harmine 
hydrochloride Group 2 (p = 0.151) relative to the 
indicators of the group without therapy (Group 4), while 
the indicators of the amitriptyline Group 3 and the group 
without therapy (Group 4) were comparable (p = 1.000) 
and did not differ from each other.
Table 4: MDA levels in brain in the groups
Kruskal–Wallis H test (α = 0.05) H (3, n = 40) =7.846 p = 0.049
MDA Group 1 Group 2 Group 3 Group 4
Group 1 1.000 0.577 0.233
Group 2 1.000 0.398 0.151
Group 3 0.577 0.398 1.000
Group 4 0.233 0.151 1.000
When comparing the indicators of the CA in the 
rats’ brain, shown in Table 5, we noticed the significant 
differences between the treatment groups and Group 4. 
Descriptive statistics, showing a twofold increase in CA 
in the treatment groups, proved significant differences 
in multiple comparisons: CA in Group 4 was lower than 
that in Group 1 of the placebo drug (p = 0.000), Group 
2 of harmine hydrochloride (p = 0.001), and Group 3 
of amitriptyline (p = 0.003). However, when comparing 
the treatment groups between each other, we found 
no significant differences and the indicators were 
comparable (p = 1.000).
The results of the RCDP evaluation showed 
that the placebo (Group 1) and harmine hydrochloride 
(Group 2) groups showed significantly lower values 
compared to Group 4, whereas this effect was 
not observed in the amitriptyline group (Group 3). 
However, the RCDP level in the harmine hydrochloride 
group (Group 2) was significantly lower than in the 
amitriptyline group (Group 3). The assumption of the 
absence of significant changes in MDA in the treatment 
groups was confirmed; however, there was a trend 
toward a decrease in MDA values in the placebo 
(Group 1) and harmine hydrochloride (Group 2) groups. 
When analyzing the CA levels in brain tissue material 
comparably, we identified the significant differences 
between all therapeutic groups and the group of animals 
that was euthanized immediately after the formation of 
the stress model (Group 4). There were no differences 
between the three treatment groups in terms of CA 
parameters.
Discussion
The effect of chronic stress on the body’s 
biochemical processes is mediated by the complex 
interconnections of mental, somatic, and neurohumoral 
reactions of an individual organism. The most studied 
model for the reproduction of the psychopathological 
complex is the CUMS model, which validity and 
predictive value have been confirmed with decades 
of experiments; currently, CUMS model is used to 
assess the antidepressant activity of pharmacological 
drugs [10]. The use of this model is justified for 
studying the pathogenetic mechanisms of the 
depressive disorders development and assessing the 
antidepressant action of drugs because the model 
proved to demonstrate a satisfactory response to 
substances with this type of pharmacological effect. 
Adaptation disorders arising against the background of 
chronic stress exposure, in our opinion, fully correspond 
to the CUMS model, making the confirmation of the 
major depressive disorder unneeded. Based on 
the DSM-V definition of depressive disorder with its 
possible development against the background of 
increased anxiety, the CUMS model allows to evaluate 
the anxiolytic effects of the studied drugs. Previously, 
we published a study of the behavioral reactions of 
rats, where experimental animals experienced anxiety 
and depressive reactions, which changed their intensity 
during therapy [20]. However, the present research 
Table 5: CA levels in brain in the groups
Kruskal–Wallis H test (α = 0.05) H (3, n = 40) =22.55 p = 0.000
CA Group 1 Group 2 Group 3 Group 4
Group 1 1.000 1.000 0.000
Group 2 1.000 1.000 0.001
Group 3 1.000 1.000 0.003
Group 4 0.000 0.001 0.003
CA: Catalase activity
A - Basic Sciences Physiology
696 https://www.id-press.eu/mjms/index
was aimed at studying the biochemical changes in the 
brain tissues, which is the basis for the formation of 
psychopathological syndromes.
We assessed the dynamics of changes in 
indicators taking into account the presence of the group 
receiving placebo (Group 1). We were able to use this 
group to evaluate the autoregulation of biochemical 
processes in the brain after exposure to chronic 
stress. The intact group of animals was not used in the 
experiment for ethical reasons. Harmine hydrochloride 
was included in the study as a drug with high oral 
bioavailability, which fundamentally distinguishes it from 
previously used parenteral forms that reduce patients’ 
compliance with therapy. Beta-carboline compounds are 
known to act as inverse agonists for the benzodiazepine 
binding site of the gamma-aminobutyric acid type A 
receptors and have the effect opposite to anxiolytic 
benzodiazepines [15]. Beta-carboline alkaloids exhibit 
a wide range of psychopharmacological effects, binding 
to benzodiazepine, imidazoline, serotonin, and opiate 
receptors, as well as inhibiting MAO [11]. Harmine’s 
multidirectional receptor activity suggests its potential 
effect in stress-induced disorders of various types. 
At the same time, the study of markers of oxidative 
metabolism makes it possible to assess the safety of its 
effect on the brain tissue.
The reference drug in the study was amitriptyline, 
typically used as a standard drug in the treatment of 
stress, in particular depressive and anxiety disorders. 
Amitriptyline, being a tricyclic antidepressant, mediates 
its action by increasing the synaptic concentration of 
serotonin and/or norepinephrine in the central nervous 
system through inhibition of their reuptake by the 
presynaptic neuronal membrane pump [29]. Amitriptyline 
was chosen as a reference drug of choice when 
conducting studies of psychotropic activity because of 
its well-known effects and short duration of treatment 
needed to reach high and rapid efficacy.
Our study shows that in the brain of rats 
treated with harmine hydrochloride, the level of 
RCDP was twice lower than in the group of rats right 
after experiencing CUMS and significantly lower 
than in rats receiving amitriptyline. Based on these 
data, we can talk about the neuroprotective effect of 
harmine hydrochloride by limiting the processes of 
protein carbonylation, which is characteristic of the 
autoregulatory mechanism, confirmed in the placebo 
group. However, amitriptyline did not demonstrate 
a limiting effect on the carbonylation process, which 
should be considered to be an unfavorable factor 
due to the prolongation of pathochemical processes 
in the brain tissue. Perhaps, the therapeutic effect of 
amitriptyline in anxiety and depressive disorders is 
mediated by other mechanisms. Yet, the question 
of the effect of amitriptyline on carbonylation should 
be contemplated further to exclude the likelihood of 
accumulation of large molecules, including amyloid 
proteins, with prolonged use of the drug, which is 
assumed by current clinical guidelines. It should be 
noted that a significant difference in the RCDP level in 
the amitriptyline group was revealed only in comparison 
with harmine hydrochloride in the absence of significant 
differences from placebo. Thus, we can conclude 
about the beneficial effect of harmine hydrochloride 
on the processes of oxidative modification of proteins. 
We can assume that the behavioral reactions, 
developing when exposed to chronic stress, are in 
part a direct consequence of the oxidative modification 
of small molecules such as dopamine, epinephrine, 
norepinephrine, serotonin, and others, leading to 
deactivation of the brain neurotransmitters. Perhaps, 
either this mechanism manifests most clearly under the 
conditions of the unpredictably alternating stress factors, 
preventing adaptation, or excessively long exposure to 
the same type of stress leads to maladjustment with 
depletion of the pool of neurotransmitters.
Existing studies of lipid peroxidation, using 
MDA as a marker, indicate the activation of lipid 
peroxidation processes in stress [30]. However, 
the authors used the combined score of MDA and 
4-hydroxyalkenals without specifying the percentage 
of each marker. According to the results of our study, 
there were no significant differences in the MDA level 
between groups, but the tendency toward a decrease of 
this marker was most pronounced in animals receiving 
harmine hydrochloride and placebo. The revealed trend 
demonstrates the absence of the damaging effect of 
harmine hydrochloride, which activity is comparable to 
the autoregulation processes and contingently exceeds 
the effect of amitriptyline. Probably, it is necessary to 
determine the concentration of MDA in the regions of 
the brain that is most involved in the development of 
behavioral disorders, such as the hippocampal and 
prefrontal regions, as was done by the previously 
mentioned researchers. Our previous studies showed 
statistically significant deviations in MDA levels in 
plasma and erythrocytes of rats with the CUMS 
model [18]. The use of a different marker in the study 
of lipid peroxidation processes in the brain may also be 
recommended.
The assessment of CA confirmed that exposure 
to chronic stress leads to inhibition of catalase, as the 
brain of animals immediately after the formation of the 
CUMS model contained low levels of it. A decrease in 
CA and, as a consequence, in antioxidant protection 
under chronic stress can be a factor in the subsequent 
progression of the associated pathochemical processes. 
However, the results obtained in all treatment groups 
demonstrated a significant increase in CA, which may 
indicate the restoration of enzyme activity after the 
cessation of stress. We suggest that catalase reactivation 
can be considered one of the triggering mechanisms 
of the neurohumoral homeostasis autoregulation in 
the brain. The study of CA under conditions of longer 
chronic stress may be of value in understanding the 
development of long-term adaptation disorders.
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Conclusion
The study of the mechanisms involved in 
the oxidative metabolism shows that biochemical 
processes in the brain of rats under conditions of 
chronic stress and after its cessation demonstrate 
different degrees of involvement. Regulation of reactive 
oxygen species concentration is supported by the 
interaction of prooxidant and antioxidant mechanisms. 
Chronic stress acts as a prooxidant factor that activates 
protein carbonylation and inhibits CA in the rats’ brain. 
MDA was the least sensitive marker of the oxidative 
stress, despite the high level of lipid metabolism in 
the brain. The effect of using harmine hydrochloride 
was comparable within the studied parameters with 
placebo, slightly exceeding it in limiting the processes 
of protein carbonylation. According to the studied 
markers, harmine hydrochloride is significantly superior 
to amitriptyline, the influence of which on carbonylation 
processes requires further study in case of its possible 
prolongation of the stressogenic effect.
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